Inogen, Inc
Price
FilingsNewest: 8-K, Material agreementSep 30 →InsidersNo open-market buys. 1 insider sold $70,328 in 1 sale, on a 10b5-1 plan.→HoldersBlackRock 6.5%Armistice Capital 4.1%Vanguard 3.9%→Financing →PeersClosest companies: TCMD, LUNG, BVS→
From the filings
Figures
- Revenue
- $303.6Mlast 12 months
- Net income
- $20.9Mlast 12 months
- Operating cash flow
- −$1.1Mlast 12 months
- Cash and equivalents
- $87.3Mat the last balance sheet
- Shares outstanding
- 26.7M shareson issue